WIRE — The rising demand for GLP-1 medications like Ozempic and Wegovy, which can cost thousands of dollars per patient each year, has weighed on the expenses of employers in the US.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.